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Paracetamol is an analgesic-antipyretic compound derived 
from p-aminophenol. Though paracetamol has good efficacy and 
safety on consumption, parasetamol has hepatotoxic effect as its     
adverse drug reaction. 4-[N-(4-hydroxyphenyl)carboxymidoyl]-2-
methoxyphenol is one of p-aminophenol derivative that was 
already been determined in silico using molecular docking PLANTS 
method, and it was known that 4-[N-(4-hydroxyphenyl) 
carboxymidoyl]-2-methoxyphenol has analgesic effects more 
potent and has hepatotoxic adverse effect lower than 
paracetamol. 4-[N-(4-hydroxyphenyl)carboxymidoyl]-2-methoxy-
phenol can be synthesized through reaction of p-aminophenol with 
vanillin under acid condition. The synthesized products were 
recrytalized, dried, and the purity was determined with melting 
point determination and Thin Layer Chromatography. The 
structure of pure crystals were elucidated using IR, 1H-NMR, C-
NMR, and Mass Spectroscopy. The analgesic evaluation was 
carried in vivo using writhing test method. The synthesized 
compound were divided into three dosage variations, 0,5; 1; and 
2mol equivalent to 100mg/kgBB of paracetamol (reference drug). 
4-[N-(4-hydroxyphenyl)carboxymidoyl]-2-methoxyphenol with 
1mol dosage has analgesic activity better than paracetamol but 
the difference was not significant. 
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INTRODUCTION 
Paracetamol is a non-opiate synthetic 
compound derived from p-aminophenol and it 
has analgesic-antipyretic effects (McEvoy, 
2002). Parasetamol acted as selective inhibitor 
of cyclo-oxygenase-2 (COX-2) enzyme, worked 
by inhibit inflammatory reaction (Anderson, 
2008; Hinz and Brune, 2012; Hinz et al.., 2009). 
Paracetamol was metabolized by 
CYP450 enzyme through oxidation, and it 
produced a N-acetyl-p-benzoquionimin, NAPQI 
(Aripin and Choonara, 2009; Vale, 2007). 
NAPQI was a hepatotoxic compound 
(Mutschler, 1986). The level of hepar damage 
caused by paracetamol was depended on 
dosage consumption (Vale, 2007). On theraphy 
dose, paracetamol was relatively safe and non-
toxic. The toxicity of paracetamol appeared on 
acute consumption of more than 10 g and on 
chronic consumption of 3-4g/day. New p-
aminophenol derivative that has more potent 
analgesic activity dan has lower hepatotoxic 
adverse effect can be found through 
modification of p-aminophenol structure. 4-[N-
(4-hydroxyphenyl) carboxymidoyl]-2-methoxy-
phenol, the is one of p-aminophenol derivative 
and it was already been test in silico using 
molecular docking PLANTS method. 4-[N-       
(4-hydroxyphenyl)-carboxymidoyl]-2-methoxy-
phenol (the authors shorted the name as 
PAPVN) has -75,0088 of docking score and 
paracetamol has -67,3820 of docking score. The 
smallest or the bigger negative value of  
docking score, the more stable the binding 
mode of drug molecules with its receptor, so 
the more potent the effect of molecule acted as 
drug (Purnomo, 2011). Based on in silico 
evaluation it can be said that PAPVN has more 
potent analgesic activity than paracetamol, and 
based on structure-activity relationship it can be 
said that PAPVN has lower hepatotoxic 
adverse effect than paracetamol. 
PAPVN can be synthesized through 
reaction of p-aminophenol with vanillin under 
acid condition. The analgesic evaluation            
was carried in vivo using writhing test as 
Pudjono 
Volume 27 Issue 2 (2016) 100 
method, against Balb/c strain mice induced 
acetic acid. 
 
MATERIALS AND METHODS 
Materials needed for PAPVN synthesis 
were p-aminophenol for synthesis (Merck), 
vanillin, ethanol (Merck), methanol, 
chloroform, HCl 37%, silica gel GF254 plate 
(Merck), spectroscopies : IR (Perkin Elmer 
FTIR 100); 1H-NMR and C-NMR (Jeol 
JNMECA500); LC-MS.  
Materials needed for analgesic activity 
evaluation of PAPVN using writhing test 
method were Balb/c strain mice (2-3 months); 
PAPVN (synthesized products); CMC-Na 0.5% 
(b/ν) suspensions; paracetamol 0.5% (b/ν) 




Fit a 100mL round –bottom flask to a 
reflux condenser, and mix p-aminophenol 
(2.2g) with 40mL water and then  HCl 37% was 
added drop by drop until all of p-aminophenol 
was dissolved in aquadest. Vanillin (3.04g) was 
added into round bottom boiling flask and 
shaked lightly. The mixture was refluxed using 
Liebig as condensor, for 2h. The solution 
obtanined was moved into 250mL Erlenmeyer 
flask, then it was cooled using ice; the purpose 
is to build the synthesized crystals. The 
obtanined wet crystals were recrystalized using 
ethanol as the solvent. The obtained pure 
crystals were dried in an oven at 50°C for 1 day. 
The purity of crystals were determined its 
melting point and Thin Layer Chromatography 
using silica gel GF254 plate with 
chlorofom:methanol (7:3) as eluent. The 
structure elucidation was carried using IR, 1H-
NMR, C-NMR, dan LC-MS spectroscopy.  
  
Writhing Test 
The animal subjects used in this test 
were Balb/c strain mice, with 20-35g range in 
weight and 2-3 months in age, and it was 
obtained form Faculty of Pharmacy, Gadjah 
Mada University, Yogyakarta, Indonesia. This 
experiment was performed following the 
writhing test method of Turner, 1965. Thirty 
mices were fasten for 12h, and then allocated 
into 5 groups of 6 mices each. Group I acted as 
negative control, in this group the mices 
received 0.5mL CMC-Na 0.5% oral 
administration (p.o). Group II acted as 
reference group, in this group the mices 
received 0.5mL paracetamol 100mg/kg p.o. 
Group III-IV were the test groups, the mices 
received 0.5mL PAPVN p.o with the dosage            
of each group were 81mg/kg; 162mg/kg   and 
324mg/kg   paracetamol.  
The 0.3mL acetic acid 200mg/kg was 
given intraperitonial to each group after oral 
administration of the test compound. The 
number of writhes induced in each mice was 
counted every 5min for 60min. The percent 
(%) of analgesic protection was calculated and 
statistically analyzed with non-paramteric test 
of ANOVA (level of confidence 95%) using 
SPSS version 22.1 for windows software. 
 
RESULTS AND DISCUSSION 
PAPVN was synthesized from the 
reaction of p-aminophenol and vanillin in 
aquadest, and it was catalyzed by HCl. The 
occurred reaction was nucleophilic addition of 
amine, forming the imine group (Figure 1). The 
free aromatic amine group in p-aminophenol 
reacted to carbonyl group in vanillin, resulted in 
addition reaction and releasing of water (H2O), 




Figure 1. Nucleophilic addition of amine in p-
aminophenol and vanillin, forming imine group 
in PAPVN structure 
 
In the LC-MS results, there was only one 
peak of compound at 2.41 min of the retention 
time, so it can be said that the synthesized 
compound was pure, free of residue and by 
product. From the determination of melting 
point, PAPVN has a  melting point 165-168°C. 
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Figure 3. Spectra of 1H-NMR 
 




















9.0642 1 Singlet H-C=N 7.6497 0.978 ≈ 1 Doublet 
 




6.9791 2.317 ≈ 2 Doublet 
 
7.6497 2.101 ≈ 2 Doublet 
 
4.0230 3.024 ≈ 3 Singlet -O-CH3 
7.2165 1.072 ≈ 1 Doublet 
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Figure 4. Spectra of C-NMR 
 
Table IV. Results of statistical analysis of % analgesic protection using one-way ANOVA 
 
 







95% Confidence Interval 
 Lower Bound Upper Bound 
LSD Reference 
Group 
Negative Control -51.00000* 12.66943 .000 -77.1484 -24.8516 
Dose 81mg/kg -4.83333 12.66943 .706 -30.9817 21.3151 
Dose 162.5mg/kg -7.76667 13.28781 .564 -35.1914 19.6580 
Dose 324.5mg/kg -4.00000 12.66943 .755 -30.1484 22.1484 
Negative 
Control 
Reference Group 51.00000* 12.66943 .000 24.8516 77.1484 
Dose 81mg/kg 46.16667* 12.66943 .001 20.0183 72.3151 
Dose 162.5mg/kg 43.23333* 13.28781 .003 15.8086 70.6580 
Dose 324.5mg/kg 47.00000* 12.66943 .001 20.8516 73.1484 
Dose 81 
mg/kg 
Reference Group 4.83333 12.66943 .706 -21.3151 30.9817 
Negative Control -46.16667* 12.66943 .001 -72.3151 -20.0183 
Dose 162.5mg/kg -2.93333 13.28781 .827 -30.3580 24.4914 
Dose 324.5mg/kg .83333 12.66943 .948 -25.3151 26.9817 
Dose 162.5 
mg/kg 
Reference Group 7.76667 13.28781 .564 -19.6580 35.1914 
Negative Control -43.23333* 13.28781 .003 -70.6580 -15.8086 
Dose 81mg/kg 2.93333 13.28781 .827 -24.4914 30.3580 
Dose 324.5mg/kg 3.76667 13.28781 .779 -23.6580 31.1914 
Dose 324.5 
mg/kg 
Reference Group 4.00000 12.66943 .755 -22.1484 30.1484 
Negative Control -47.00000* 12.66943 .001 -73.1484 -20.8516 
Dose 81mg/kg -.83333 12.66943 .948 -26.9817 25.3151 
Dose 162.5mg/kg -3.76667 13.28781 .779 -31.1914 23.6580 
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 From the LC-MS results, the molecular 
weight of synthesized compound was obtained; 
it was 244.37 (m/z). This molecular weight is 
suitable with the theoritic molecular weight of 
PAPVN (243.26g/mol). 
Spectra data of IR (cm-1, KBr) were: 
1376 (m, C-O str); 1595 (s, -C6H5 str.); 1652(m, 
C=N str); 1891(w-trisubstituted benzene); 
3077-3558(s, OH).  
Based on the analysis of 1H-NMR and 
C-NMR spectra, it can be interpreted that the 
carbon framework and compound structure is 
suitable with the theoritic structure of PAPVN. 
This C-NMR interpretation results is being a 
support to the 1H-NMR interpretation. 
From the interpretation results of fourth 
spectra it can be summarize that the 
synthesized compound is a correct PAPVN 
compound. The analgesic activity evaluation 
was conducted using writhing test method. 
Cumulative writhes of the mices were 
statistically analyzed using one-way ANOVA 
with level confidence of 95%. The data were 
distributed normally and homogenized. 
The results table above show that the 3 
doses of PAPVN (81; 162.5; 324.5mg/kg) have 
bigger value in mean difference of writhes than 
that of reference group, but it do not have 
significant difference between the two. So it 
can be said that PAPVN compound has 
analgesic activity but it is not different than that 
of paracetamol. The 3 doses of  PAPVN also 
do not have significant difference of mean 
whrites among each other. The 3 doses of 
PAPVN do not have analgesic activity differ 
from each other, so it can be said that rising up 
the dose is not going to rising up the analgesic 
response. Reference group and negative control 
have a significant difference in mean whrites, it 





2-methoxyphenol can be synthesized through 
reaction of p-aminophenol with vanillin under 
acid condition. The compound has analgesic 
activity but its not better than paracetamol. 
Further research on toxicity of 4-[N-(4-
hydroxyphenyl)-carboxymi-doyl]-2-methoxy-
phenol was interesting to investigate. 
 
ACKNOWLEDGEMENT 
This research was financially supported 
by Direktorat Jenderal Pendidikan Tinggi 
(DIKTI). The researchers are grateful to 
Lembaga Ilmu Pengetahuan Indonesia (LIPI), 
Sofa Fajriah and Puspa Dewi N. Lotulung for 
technical support.  
 
REFERENCES 
Anderson BJ. 2008. Paracetamol 
(acetaminophen): mechanisms of action. 
Pediatric Anesthesia. 18: 915-921. 
Aripin KNBN. dan Choonara I. 2009. The 
management of paracetamol poisoning. 
Paediatrics and Child Health. 19(11): 492-
497. 
Furniss BS., Hannaford AJ., Smith PWG., dan 
Tatchell AR. 1989. Vogel’s Textbook of 
Practical Organic Chemistry 5th Edition. 
Pearson Prentice Hall. London. pp 135-
241. 
Hinz B., Brune K. 2012. Paracetamol and 
cyclooxigenase inhibition: is there a 
cause for concern? Ann Rheum Dis. 71: 
20-25. 
Hinz B., Cheremina O., Brune K. 2008. 
Acetaminophen (paracetamol) is a 
selective cyclooxigenase-2 inhibitor in 
man. The FASEB Journal. 22: 383-390. 
Mutschler E. 1986. Dinamika Obat Edisi V. 
Translated by Kosasih Padmawinata. 
Penerbit ITB. Bandung. pp 177-201. 
Purnomo H. 2011. Kimia Komputasi: Molecular 
Docking Plants. Pustaka Pelajar. 
Yogyakarta. 
Turner RA. 1965. Screening Methods in 
Pharmacology. Academic Press. New York. 
pp  100-117. 
Vale A. 2007. Paracetamol (acetaminophen). 
Medicine. 35(12): 643-645. 
 
